Moderately bullish activity in Pfizer (PFE), with shares up 14c, or 0.54%, near $26.91. Options volume extremely heavy with 217k contracts traded and calls leading puts for a put/call ratio of 0.92, compared to a typical level near 0.65. Implied volatility (IV30) is higher by 0.6 points near 25.7,and above the 52wk median, suggesting an expected daily move of $0.44. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer price target raised to $36 from $35 at Guggenheim
- Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
- Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
- Pfizer (PFE) Balances Trial Setback With Quiet Pipeline Push
- Pfizer recommends shareholders reject mini-tender offer by Tutanota